Policy / executive actionupcoming
MAHA peptide-access framework — expected HHS rollout
Thursday, October 15, 2026 · Federal agency
The HHS / Make America Healthy Again administration is expected to publish a peptide-access framework in Q4 2026 — outlining 'Ethical Channel' compounding pathways and signaling potential FDA Category reclassification for non-injectable peptides.
Peptides affected
- BPC-157
- Sermorelin
- Cerebrolysin
- GHK-Cu
- Selank
Sources & further reading
- Primary source · Federal agency policy / executive action
Regulatory event entry on peptide regulatory calendar. Event details may change as the agency publishes updates — verify against the primary source above before acting on the timeline.